PUBLICATIONS DATABASE
Current controversies and challenges in allergic rhinitis management
Expert Review of Clinical Immunology
29 August 2015
David Price, Peter Smith, Peter Hellings, Nikolaos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan, Jean Bousquet
Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma
Annals of the American Thoracic Society
1 June 2015
Elliot Israel, Nicolas Roche, Richard J Martin, Gene Colice, Paul M Dorinsky, Dirkje Postma, Theresa W Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidti, Victoria Thomas, David Price
Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma
Journal of Allergy and Clinical Immunology: In Practice
29 May 2015
Willem M.C. van Aalderen, Jonathan Grigg, Theresa W Guilbert, Nicolas Roche, Elliot Israel, Richard J Martin, Gene Colice, Dirkje Postma, Elizabeth V Hillyer, Annie Burden, Victoria Thomas, Julie von Ziegenweidti, David Price
Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma
American Journal of Respiratory and Critical Care Medicine
15 April 2015
Nicolas Roche, Dirkje Postma, Gene Colice, Annie Burden, Theresa W Guilbert, Elliot Israel, Richard J Martin, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Julie von Ziegenweidti, David Price
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
Journal of Asthma and Allergy
14 January 2015
David Price, Alan Kaplan, Rupert Jones, Daryl Freeman, Annie Burden, Shuna Gould, Julie von Ziegenweidti, Muzammil Ali, Christine King, Mike Thomas
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
International Journal of Chronic Obstructive Pulmonary Disease
17 October 2014
Dirkje Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem M.C. van Aalderen, Jonathan Grigg, Annie Burden, Elizabeth V Hillyer, Julie von Ziegenweidti, Gokul Gopalan, David Price
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
NPJ Primary Care Respiratory Medicine
9 October 2014
Richard J Martin, David Price, Nicolas Roche, Elliot Israel, Willem M.C. van Aalderen, Jonathan Grigg, Dirkje Postma, Theresa W Guilbert, Elizabeth V Hillyer, Annie Burden, Julie von Ziegenweidti, Gene Colice
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
International Journal of Chronic Obstructive Pulmonary Disease
7 September 2014
Claire Brockwell, Sundari Ampikaipakan, Darren W Sexton, David Price, Daryl Freeman, Mike Thomas, Muzammil Ali, Andrew Wilson
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
International Journal of Chronic Obstructive Pulmonary Disease
27 August 2014
David Price, Daniel West, Guy Brusselle, Kevin Gruffyd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, Katsiaryna Bichel
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study
BMC Pulmonary Medicine
16 January 2014
Henry Chrystyn, David Price, Mathieu Molimard, John Haughney, Sinthia Bosnic-Anticevich, Federico Lavorini, John Efthimiou, Dawn Shan, Erika Sims, Annie Burden, Catherine Hutton, Nicolas Roche
Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Clinical and Translational Allergy
7 November 2013
David Price, Dermot Ryan, Annie Burden, Julie von Ziegenweidti, Shuna Gould, Daryl Freeman, Kevin Gruffyd-Jones, Anne Copland, Clifford Godley, Alison Chisholm, Mike Thomas
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
Primary Care Respiratory Journal
2 November 2013
David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffyd-Jones, Federico Lavorini, Tim Harris, Annie Burden, Jeremy Brockman, Christine King, Alberto Papi
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
Journal of Allergy and Clinical Immunology
15 April 2013
Gene Colice, Richard J Martin, Elliot Israel, Nicolas Roche, Neil Barnes, Annie Burden, Peter Polos, Paul M Dorinsky, Elizabeth V Hillyer, Amanda Lee, Alison Chisholm, Julie von Ziegenweidti, Francesca Barion, David Price
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
The Lancet Respiratory Medicine
13 February 2013
Rupert Jones, David Price, Dermot Ryan, Erika Sims, Julie von Ziegenweidti, Laurence Mascarenhas, Annie Burden, David Halpin, Robert Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm, Eric Bateman, The Respiratory Effectiveness Group